Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.


Journal

World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544

Informations de publication

Date de publication:
25 May 2020
Historique:
received: 16 03 2020
accepted: 06 05 2020
entrez: 27 5 2020
pubmed: 27 5 2020
medline: 9 3 2021
Statut: epublish

Résumé

Selecting the treatment procedure for cancer patients is a challenging task. We report our initial experience of complete laparoscopic radical nephroureterectomy (RNU) for patients with upper urinary tract urothelial cancer (UTUC). A total of four patients with UTUC underwent complete laparoscopic RNU combined with transvesical laparoscopic excision of the distal ureter using three 5-mm ports. Transvaginal specimen extraction was applied in female patients to reduce incisional pain and improve cosmesis. Peri-operative complications were evaluated using the Clavien-Dindo classification system. Postoperative pain was evaluated during hospitalization using a numeric pain rating scale (scales of 1 to 10). Patients who underwent retroperitoneal laparoscopic surgery combined with open excision of the distal ureter during the same period were included as a control group (conventional RNU, consisting of laparoscopic nephrectomy combined with open bladder cuff excision) for pain scale evaluation. The novel surgery was successfully completed for all four patients (two males and two females). The mean pneumoperitoneum time for retroperitoneoscopic nephroureterectomy and specimen extraction was 174 min, while the mean pneumovesicum time for the ureteral orifice excision was 88 min. One male patient had bladder leakage at the suture site of the bladder wall, which lasted for 2 weeks. No patient experienced recurrent disease during the follow-up period (median, 10 months). Mild to moderate pain lasted for 5 or 6 days after RNU. A couple of days after surgery, the numeric pain rating scale of complete laparoscopic RNU and conventional RNU group reached its peak level at 3.0 ± 1.8 and 5.3 ± 2.8, respectively. There was no statistical difference in the degree of postoperative pain (P = 0.31). We described our initial experience and outcome of complete laparoscopic RNU for UTUC. Further experience and research are required to determine whether this advanced laparoscopic technique yields better outcomes and has true clinical value.

Sections du résumé

BACKGROUND BACKGROUND
Selecting the treatment procedure for cancer patients is a challenging task. We report our initial experience of complete laparoscopic radical nephroureterectomy (RNU) for patients with upper urinary tract urothelial cancer (UTUC).
METHODS METHODS
A total of four patients with UTUC underwent complete laparoscopic RNU combined with transvesical laparoscopic excision of the distal ureter using three 5-mm ports. Transvaginal specimen extraction was applied in female patients to reduce incisional pain and improve cosmesis. Peri-operative complications were evaluated using the Clavien-Dindo classification system. Postoperative pain was evaluated during hospitalization using a numeric pain rating scale (scales of 1 to 10). Patients who underwent retroperitoneal laparoscopic surgery combined with open excision of the distal ureter during the same period were included as a control group (conventional RNU, consisting of laparoscopic nephrectomy combined with open bladder cuff excision) for pain scale evaluation.
RESULTS RESULTS
The novel surgery was successfully completed for all four patients (two males and two females). The mean pneumoperitoneum time for retroperitoneoscopic nephroureterectomy and specimen extraction was 174 min, while the mean pneumovesicum time for the ureteral orifice excision was 88 min. One male patient had bladder leakage at the suture site of the bladder wall, which lasted for 2 weeks. No patient experienced recurrent disease during the follow-up period (median, 10 months). Mild to moderate pain lasted for 5 or 6 days after RNU. A couple of days after surgery, the numeric pain rating scale of complete laparoscopic RNU and conventional RNU group reached its peak level at 3.0 ± 1.8 and 5.3 ± 2.8, respectively. There was no statistical difference in the degree of postoperative pain (P = 0.31).
CONCLUSIONS CONCLUSIONS
We described our initial experience and outcome of complete laparoscopic RNU for UTUC. Further experience and research are required to determine whether this advanced laparoscopic technique yields better outcomes and has true clinical value.

Identifiants

pubmed: 32450850
doi: 10.1186/s12957-020-01872-1
pii: 10.1186/s12957-020-01872-1
pmc: PMC7249636
doi:

Types de publication

Case Reports Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

Eur Urol. 2010 Jun;57(6):963-9
pubmed: 20079965
Ann Transplant. 2015 Oct 22;20:634-8
pubmed: 26489713
World J Urol. 2008 Aug;26(4):381-6
pubmed: 18431579
J Endourol. 2005 Apr;19(3):295-9
pubmed: 15865516
Eur Urol. 2015 Aug;68(2):302-10
pubmed: 25837534
J Invest Surg. 2020 Jan 6;:1-8
pubmed: 31906743
Urology. 2014 Jul;84(1):99-104
pubmed: 24813070
J Endourol. 2010 Nov;24(11):1719-20
pubmed: 20677987
J Pediatr Urol. 2008 Apr;4(2):146-9
pubmed: 18631912
Jpn J Clin Oncol. 2016 Dec;46(12):1148-1155
pubmed: 27576438
JA Clin Rep. 2017;3(1):5
pubmed: 29492444
World J Urol. 2009 Apr;27(2):253-8
pubmed: 18846375
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
J Laparoendosc Surg. 1991 Dec;1(6):343-9
pubmed: 1838941
Urology. 2002 Mar;59(3):446-50
pubmed: 11880100
Eur Urol. 2012 Jun;61(6):1142-53
pubmed: 22349569
BJU Int. 2009 Nov;104(10):1505-9
pubmed: 19426193
Actas Urol Esp. 2011 Mar;35(3):168-74
pubmed: 21354653
Scand J Surg. 2009;98(2):110-9
pubmed: 19799048
Cent European J Urol. 2012;65(2):75-9
pubmed: 24578933
J Endourol. 2007 Aug;21(8):915-8
pubmed: 17867953
BJU Int. 2009 Dec;104(11):1718-21
pubmed: 19519762
World J Surg Oncol. 2019 Apr 11;17(1):65
pubmed: 30975161
Adv Urol. 2009;:316807
pubmed: 19020654
Eur Urol. 2015 Nov;68(5):868-79
pubmed: 26188393

Auteurs

Makito Miyake (M)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. makitomiyake@yahoo.co.jp.

Nobutaka Nishimura (N)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Katsuya Aoki (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Chihiro Ohmori (C)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Takuto Shimizu (T)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Takuya Owari (T)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Shunta Hori (S)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yosuke Morizawa (Y)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Daisuke Gotoh (D)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yasushi Nakai (Y)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Satoshi Anai (S)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kazumasa Torimoto (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Nobumichi Tanaka (N)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kiyohide Fujimoto (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH